Evidence map›Paper›PMID 23683578›Full record

ArticleCell2013

Human embryonic stem cells derived by somatic cell nuclear transfer.

Masahito Tachibana, Paula Amato, Michelle Sparman, Nuria Marti Gutierrez, Rebecca Tippner-Hedges, Hong Ma, Eunju Kang, Alimujiang Fulati, Hyo-Sang Lee, Hathaitip Sritanaudomchai and 13 more

Abstract read
In one paragraph

Article in Cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 309 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
309citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

309 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Single-cell cloning and its approaches.Frontiers in cell and developmental biology · 2025
    Review
  17. New frontiers in retinal transplantation.World journal of transplantation · 2024
    Review
  18. Endothelial-specific CXCL12 regulates neovascularization during tissue repair and tumor progression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  19. Review
  20. Classes of Stem Cells: From Biology to Engineering.Regenerative engineering and translational medicine · 2024
    Article

249 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Masahito TachibanaDivision of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR 97006, USA.
Paula Amato
Michelle Sparman
Nuria Marti Gutierrez
Rebecca Tippner-Hedges
Hong Ma
Eunju Kang
Alimujiang Fulati
Hyo-Sang Lee
Hathaitip Sritanaudomchai
Keith Masterson
Janine Larson
Deborah Eaton
Karen Sadler-Fredd
David Battaglia
David Lee
Diana Wu
Jeffrey Jensen
Phillip Patton
Sumita Gokhale
Richard L Stouffer
Don Wolf
Shoukhrat Mitalipov

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Histocompatible Primate Embryonic Stem CellsR01HD057121 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MITALIPOV, SHOUKHRAT · 2009 to 2013
$3.4M
Mitochondrial Gene TherapyR01HD063276 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MITALIPOV, SHOUKHRAT · 2010 to 2014
$3.0M
Altered Nuclear TransferR01HD059946 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MITALIPOV, SHOUKHRAT · 2010 to 2014
$2.7M
Evaluation of stem cell-derived retinal pigment epithelial cells for retinal diseR01EY021214 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NEURINGER, MARTHA · 2011 to 2015
$2.1M
NEI NIH HHS EY021214NEI NIH HHS R01 EY021214NICHD NIH HHS HD057121NICHD NIH HHS HD059946NICHD NIH HHS HD063276NICHD NIH HHS R01 HD057121NICHD NIH HHS R01 HD059946NICHD NIH HHS R01 HD063276NIH HHS 8P51OD011092NIH HHS P51 OD011092
6 · The paper itself

Abstract

Reprogramming somatic cells into pluripotent embryonic stem cells (ESCs) by somatic cell nuclear transfer (SCNT) has been envisioned as an approach for generating patient-matched nuclear transfer (NT)-ESCs for studies of disease mechanisms and for developing specific therapies. Past attempts to produce human NT-ESCs have failed secondary to early embryonic arrest of SCNT embryos. Here, we identified premature exit from meiosis in human oocytes and suboptimal activation as key factors that are responsible for these outcomes. Optimized SCNT approaches designed to circumvent these limitations allowed derivation of human NT-ESCs. When applied to premium quality human oocytes, NT-ESC lines were derived from as few as two oocytes. NT-ESCs displayed normal diploid karyotypes and inherited their nuclear genome exclusively from parental somatic cells. Gene expression and differentiation profiles in human NT-ESCs were similar to embryo-derived ESCs, suggesting efficient reprogramming of somatic cells to a pluripotent state.

Indexed as

Cell LineNuclear Transfer TechniquesAdultAnimalsBlastocystCell FusionCell NucleusCell SeparationEmbryonic Stem CellsFemaleFetusFibroblastsHumansMacaca mulattaMitochondriaOocytes

Identifiers

PMID23683578
PMCPMC3772789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.